.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Citi
Accenture
Cerilliant
Queensland Health
Fuji
Fish and Richardson
Medtronic
US Army
Baxter

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,498,343

« Back to Dashboard

Which drugs does patent 7,498,343 protect, and when does it expire?


Patent 7,498,343 protects SIRTURO and is included in one NDA.

This patent has fifty-two patent family members in thirty-five countries.

Summary for Patent: 7,498,343

Title:Mycobacterial inhibitors
Abstract: The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or the general Formula (Ib) ##STR00001## the pharmaceutically acceptable acid or base addition salts thereof, the stereochemically isomeric forms thereof, the tautomeric forms thereof and the N-oxide forms thereof. The claimed compounds are useful for the treatment of mycobacterial diseases, particularly those diseases caused by pathogenic mycobacteria such as Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum. In particular, compounds are claimed in which, independently from each other, R.sup.1 is bromo, p=1, R.sup.2 is alkyloxy, R.sup.3 is optionally substituted naphthyl or phenyl, q=1, R.sup.4 and R.sup.5 each independently are hydrogen, methyl or ethyl, R.sup.6 is hydrogen, r is equal to 0 or 1 and R.sup.7 is hydrogen. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of mycobacterial diseases and a process for preparing the claimed compounds.
Inventor(s): Van Gestel; Jozef Frans Elisabetha (Beerse, BE), Guillemont; Jerome Emile Georges (Val de Reuil Cedex, FR), Venet; Marc Gaston (Le Mans, FR), Poignet; Herve Jean Joseph (Issy-les-Moulineaux Cedex 9, FR), Decrane; Laurence Francoise Bernadette (Val de Reuil Cedex, FR), Vernier; Daniel F. J. (Val de Reuil Cedex, FR), Odds; Frank Christopher (Drumoak, GB)
Assignee: Janssen Pharmaceutica N.V. (Beerse, BE)
Application Number:11/007,026
Patent Claim Types:
see list of patent claims
Compound; Composition; Use; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Janssen Therap
SIRTURO
bedaquiline fumarate
TABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► SubscribeYY
Janssen Therap
SIRTURO
bedaquiline fumarate
TABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► SubscribeYY TREATMENT OF PULMONARY MULTI-DRUG RESISTANT TUBERCULOSIS
Janssen Therap
SIRTURO
bedaquiline fumarate
TABLET;ORAL204384-001Dec 28, 2012RXYesYes► Subscribe► SubscribeYY TREATMENT OF PULMONARY MULTI-DRUG RESISTANT TUBERCULOSIS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,498,343

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Poland375523► Subscribe
New Zealand538391► Subscribe
Norway2014021► Subscribe
Norway329935► Subscribe
Norway20050476► Subscribe
Netherlands300684► Subscribe
Malaysia143564► Subscribe
MexicoPA05001052► Subscribe
MontenegroP9208► Subscribe
Luxembourg92520► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Julphar
Argus Health
Boehringer Ingelheim
Fish and Richardson
QuintilesIMS
Johnson and Johnson
Colorcon
Daiichi Sankyo
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot